Faculty

Christopher I-Fu Li

Research Professor, Epidemiology

206-667-7444

Education

MD Medicine, University of California (San Francisco), 2000
PhD Epidemiology, University of Washington, 2003
MPH Epidemiology, University of Washington, 2000

Contact

206-667-7444

Fred Hutchinson Cancer Research Center
Box 358080
1100 Fairview Ave N., M4-C308
P.O. 19024
Seattle, WA 98109
View Website »

Research Interests

Dr. Li is a cancer epidemiologist based at the Fred Hutchinson Cancer Research Center with research projects spanning cancer early detection/screening, etiology, and survivorship. He has significant expertise in cancer epidemiology and substantial experience in the design, leadership, and completion of multidisciplinary studies of cancer. Current research projects include: 1. A large population-based study of different molecular subtypes of breast cancer aimed at elucidating their risk factors and identifying novel subtype-specific tumor markers useful for predicting risk of disease recurrence (DOD Collaborative Innovator Award); 2. A nested case-control study of women with DCIS who did and did not go on to develop a second breast cancer aimed at developing novel epidemiologic, clinical, and molecular approaches for guiding clinical decision making for DCIS patients (R01); 3. Discovering and validating novel blood-based markers useful for the early detection of breast, colorectal, and ovarian cancers (U01); 4. Characterizing risk factors for second primary breast, lung, colorectal, and endometrial cancers among breast cancer survivors (R01); and 5. Discovering and validating novel biomarkers useful for assessing risk of recurrence among colorectal cancer survivors (R01 and U01). Selected leaderships activities include: 1. Serving as the co-PI of the Cancer Surveillance System (CSS), the Seattle-Puget Sound Surveillance, Epidemiology and End Results (SEER) cancer registry, 2. Chairing the DOD Breast Cancer Research Program’s Integration Panel (FY 2017), and 3. Co-chairing the 2017 AACR Conference on the Science of Cancer Health Disparities.

Recent Publications (PubMed)

Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019.
(2024 Nov 13)
Cancer Causes Control
Sheridan L, Pocobelli G, Anderson M, Li CI, Kruse GR, Tiro JA, Kamineni A

Metabolic syndrome and risks of breast cancer outcomes for luminal, triple-negative, and HER2-overexpressing subtypes.
(2024 Nov 1)
Cancer Epidemiol Biomarkers Prev
Loroña NC, Othus M, Malone KE, Linden HM, Tang MC, Li CI

Cancer Prevalence across Vertebrates.
(2024 Oct 24)
Cancer Discov
Compton ZT, Mellon W, Harris VK, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez LN, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Li CI, Zehnder A, Graham TA, Troan BV, Harrison TM, Tollis M, Schiffman JD, Aktipis CA, Abegglen LM, Maley CC, Boddy AM

Sex hormones and risk of lung and colorectal cancers in women: a Mendelian randomization study.
(2024 Oct 12)
Sci Rep 14(1): 23891
Denos M, Sun YQ, Brumpton BM, Li Y, Albanes D, Burnett-Hartman A, Campbell PT, Küry S, Li CI, White E, Samadder JN, Jenkins MA, Mai XM

Alcohol consumption and smoking history at time of diagnosis, and risk of colorectal cancer recurrence and mortality: Results from the ColoCare Study.
(2024 Oct 7)
Cancer Epidemiol Biomarkers Prev
Loroña NC, Himbert C, Ose J, Cohen SA, Strehli I, Ulrich CM, Cobos S, Jean-Baptiste E, Bloomer AM, Figueiredo JC, Gigic B, Hardikar S, Karchi M, Mutch M, Peoples AR, Schneider M, Shibata D, Siegel EM, Toriola AT, Wood EH, Li CI

Show complete publication list